NOA TRACKER

Track NCI-Designated Cancer Center Program funding.

America's Cancer Centers save lives. Access NOA releases and funding patterns across all 73 Cancer Centers to plan ahead.

Cancer Centers save lives through cutting-edge research

Over 0

Years of dedicated cancer research since established

0

NCI-Designated Cancer Centers in the CCSG network

0 +

Patients receive cancer diagnoses every year

Cancer Center Support Grant

The Cancer Center Support Grant (CCSG) program is a core pillar of America's cancer research effort. To qualify for funding, centers maintain rigorous research standards and focus on developing novel approaches to preventing, diagnosing, and treating cancer.

View NCI Data

Track FY25 distributions across NCI-Designated Cancer Centers.

Explore Notice of Award (NOA) release timelines with valuable added context, including application and program type, organizational traits, state or region, and historical funding data for each center.

Strategic Planning & Benchmarking

Compare your center's funding timeline against those at peer institutions to establish realistic expectations and recognize potential delays early on. Filter by application type, geographic region, or funding amount to identify patterns that may affect programs like yours.

Historical Context

See past funding totals to understand how policy changes, budget cycles, and external factors affect cancer research funding over time. Compare current delays to historical norms to determine whether challenges are temporary disruptions or systemic issues requiring sustained advocacy.

Advocacy & Communication

Use concrete data to strengthen conversations with institutional leadership, legislators, and funding agencies. When you can show that similar centers have received NOAs in a particular timeline but yours is still experiencing a lengthy delay, you have evidence to support requests for bridge funding or policy changes.

Strategic Applications

How research administrators can use this data

Frequently asked questions

We currently track the 73 NCI-Designated Cancer Centers - all 57 Comprehensive Cancer Centers, 9 Clinical Cancer Centers, and 7 Basic Laboratory Cancer Centers. These represent the premier cancer research institutions in the United States and receive the most significant federal funding. While there are excellent cancer research programs at other institutions, the NCI-designated centers have a unique funding structure and reporting requirements that make them particularly suitable for this type of tracking.

We primarily track P30 Cancer Center Support Grants since these are the core funding mechanisms for NCI-Designated Centers. We don’t track every individual R01 or small grant at the moment. Our focus is on significant center-level funding when it’s substantial enough to impact operations and strategic, center-level decision making.

Our primary source is the NIH RePORTER database, which we access weekly. We also monitor NIH institute announcements, institutional press releases, and official NOA documents when they're publicly available. We don't rely on rumors, social media, or unofficial sources. If we can't verify information through official channels, we mark it as pending internally until we can confirm the details. This conservative approach keeps our data reliable.

We update our Cancer Center funding data every Saturday after the NIH RePORTER database refreshes. Unlike automated feeds that can miss nuances or contain errors, we manually verify each NOA release and cross-reference it with official sources. This means you get reliable, human-checked intelligence rather than raw data dumps. Our weekly schedule also ensures you're never more than a few days behind the latest funding announcements.

Yes, that is our intent for providing the NOA Tracker. We have provided buttons within each page that enable CSV downloads of the complete dataset, updated weekly. The download includes all the fields you see in the tracker plus some additional metadata that might be useful for analysis. You're free to use this data for internal planning, presentations to leadership, or advocacy efforts. We just ask that you credit the source if you share the data publicly or use it in publications.

In the event that an error is found, we request that you reach out to us immediately through our contact form. We take data accuracy seriously and want to correct any errors quickly. When you contact us, please include the specific grant number, the error you've identified, and any supporting documentation you can provide. We typically investigate and respond to error reports within 48 hours. Your feedback helps us maintain the quality that makes this tracker valuable for the entire community.

No, the NOA Tracker is completely free to access and use. We believe funding transparency benefits the entire cancer research community, so we don't gate the data behind paywalls or registration requirements. You can bookmark the page, download the data, and share it with colleagues without any restrictions. Our goal is to support cancer research excellence, not to create barriers to information access.

Cancer research requires long-term planning and significant infrastructure investment. When funding is delayed or uncertain, it impacts everything from hiring decisions to equipment purchases to patient care protocols. By tracking funding patterns, cancer center administrators can plan more effectively, benchmark against peers, and advocate for predictable funding cycles. This transparency also helps the broader research community understand funding trends and challenges.

Questions? We'd love to connect.

Ask about the NOA Tracker, how we gather the data, or anything else. Our experts are standing by, ready to help.

We believe research is the greatest platform for progress.

We are passionate proponents of _______, committed to doing well by all of our stakeholders — our partners, employees, communities, the planet, and society as a whole. And we lead by example, spearheading initiatives in philanthropy, racial equality and justic, climate action and advocacy, and the ethical and humane use of technology.